From: Rho GTPases as therapeutic targets in Alzheimer’s disease
Mouse model | Treatment | Behavioral modification | Reference |
---|---|---|---|
C57BL/6, male, 2-month-old | CNF1 | (1) Enhanced associative emotional memories in the fear conditioning test. (2) Improved spatial learning in the water maze paradigm. | [49] |
ICR, male, 2-month-old | Y27632 | (1) Increased anxiety-related behaviors: a. Spent less time on the open arms of elevated plus-maze test. b. Frequently froze in the fear-conditioning test. c. Decreased head-dipping behavior in the hole-board test. (2) No spatial learning alteration in the Y-maze test. | [89] |
TgCRND8, male/female, 4-month-old | CNF1 | (1) Decreased locomotor hyperactivity in the open field test. (2) Corrected the deficit of spatial learning in the water maze paradigm. | [78] |
ApoE4, male/female, 12-month-old | CNF1 | (1) Improved spatial learning memory in the water maze paradigm. (2) Enhanced the non-spatial learning memory in passive avoidance test. (3) CNF1 treatment did not induce anxiety behaviors. (No significant difference was observed in the elevated plus maze and open field test) | [81] |
MeCP2-308, female, 12-month-old | CNF1 | (1) Reversed the spatial reference memory deficit in the Barne maze test. | [83] |
αPIX/ARHGEF6 knockout, male, ~6-month-old | None | (1) Slow adaptation of new target in the water maze test. (2) Intact spatial learning memory was observed in the eight-arm radial maze test. (3) Overly increased activity to the unknown object in the open field test. (4) Displayed a deficit in the complex spatial learning ability in the IntelliCage test. | [88] |
Arg –/– , male, ~4-month-old | None | (1) Failed to distinguish the novel object in the object recognition task. | [86] |